Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin

Medicine & Life Sciences

• translationally-controlled 1 tumor protein 90%
• Exenatide 76%
• Protein Domains 56%
• Nose 45%
• Insulin 38%
• Peptides 9%
• Hypoglycemic Agents 9%
• Intranasal Administration 6%
• Mutant Proteins 5%
• Blood Glucose 4%
• Proteins 3%
• Animals 2%
• Pharmaceutical Preparations 2%
• Therapeutics 0%

Chemical Compounds

• Exendin-4 100%
• Nasal 74%
• Insulin Derivative 57%
• Intranasal 38%
• Protein 23%
• Antidiabetic Agent 19%
• Peptide 13%
• Glucose 5%
• Drug 4%